Nanoformulation mediated silencing of P-gp efflux protein for the efficient oral delivery of anti-leishmanial drugs: Shabi Parvez, Archana Karole, Hayagreeva Dinakar Yirivinti, Shyam Lal Mudavath*, (2022) Journal of Drug Delivery Science and Technology, (Just Accepted): 103959. DOI: https://doi.org/10.1016/j.jddst.2022.103959

Organ restricted delivery through stimuli responsive nanocarriers for lung cancer therapy: Yirivinti Hayagreeva Dinakar, Archana Karole, Shabi Parvez, Vikas Jain, Shyam Lal Mudavath*, (2022) Life Sciences, (Just Accepted). DOI: https://doi.org/10.1016/j.lfs.2022.121133

Role of STAT3 in the initiation, progression, proliferation and metastasis of breast cancer and strategies to deliver JAK and STAT3 inhibitors: Yirivinti Hayagreeva Dinakar, Hitesh Kumar, Shyam Lal Mudavath, Rupshee Jain Ramkishan Ajmeer Vikas Jain, (2022) Life Sciences, (Just Accepted): . DOI: https://doi.org/10.1016/j.lfs.2022.120996

Hijacking the intrinsic Vitamin B12 pathway for oral delivery of nanoparticles ensuing an enhanced in vivo anti-leishmanial activity: Singh, A.; Yadagiri, G.; Javaid, A.; Sharma, S.S.; Verma, A.; Singh, O.P.; Sundar, S.; Mudavath, S.L.*, (2022) Biomaterials Science, (Just Accepted): . DOI: https://doi.org/10.1039/D2BM00979J

Transport mechanism of hydroxy-propyl-beta-cyclodextrin modified solid lipid nanoparticles across human epithelial cells for the oral absorption of antileishmanial drugs: Shabi Parvez, Archana Karole, Shyam Lal Mudavath*, (2022) Biochimica et Biophysica Acta (BBA) - General Subjects, 130157: . DOI: https://doi.org/10.1016/j.bbagen.2022.130157

Fabrication, Physicochemical characterization and In vitro anticancer activity of Nerolidol encapsulated Solid Lipid Nanoparticles in Human Colorectal Cell Line: Shabi Parvez, Archana Karole,Shyam Lal Mudavath*, (2022) Colloids and Surfaces B: Biointerfaces, Accepted: . DOI: https://doi.org/10.1016/j.colsurfb.2022.112520

Effervescent based nano-gas carrier enhanced the bioavailability of poorly aqueous soluble drug: A comprehensive mechanistic understanding  : Archana Karole, Shabi Parvez, Richa Singh Thakur, Shyam Lal Mudavath*, (2022) Journal of Drug Delivery Science and Technology, . DOI: https://doi.org/10.1016/j.jddst.2022.103167

Carboxymethyl chitosan modified lipid nanoformulations as a highly efficacious and biocompatible oral anti-leishmanial drug carrier system: Aakriti Singh, Ganesh Yadagiri , Manorma Negi, Anurag Kumar Kushwaha, Om Prakash Singh, Shyam Sundar, and Shyam Lal Mudavath*, (2022) International Journal of Biological Macromolecules, 204: 373-385. DOI: https://doi.org/10.1016/j.ijbiomac.2022.02.006

Coalition of biological agent (melatonin) with chemotherapeutic agent (amphotericin B) for combating visceral leishmaniasis via oral administration of modified solid lipid nanoparticles: Parvez S, Yadagiri G,Arora K, Javaid A,Kushwaha A.K.,Singh O.P.,Sundar S,Mudavath S.L*., (2021) ACS Biomaterials Science & Engineering, . DOI: https://doi.org/10.1021/acsbiomaterials.1c00859

Downshifting and upconversion dual mode emission from lanthanide doped GdPO4 nanorods for unclonable anti-counterfeiting: Pushpendra, I. Suryawanshi, S. Srinidhi, S. Singh, R. Kalia, R. K. Kunchala, S.L. Mudavath, B.S. Naidu*, (2021) Mater. Today Commun., 26: 102144. DOI: 10.1016/j.mtcomm.2021.102144

Detection of Latent Fingerprints using Luminescent Gd0.95Eu0.05PO4 Nanorods: Pushpendra, I. Suryawanshi, R. Kalia, R. K. Kunchala, S.L. Mudavath, B.S. Naidu*, (2021) J. Rare Earths, 40: 572-578. DOI: 10.1016/j.jre.2021.01.015

Nanodiagnostics in Leishmaniasis: A New Frontier for Early Elimination: Mallikarjuna Rao Gedda, Prasoon Madhukar, Ashish Shukla, Shyam Lal Mudavath, Onkar Nath Srivastava, Om Prakash Singh and Shyam Sundar, (2020) WIREs Nanomedicine and Nanobiotechnology, Accepted: 1-22. DOI: 10.1002/wnan.1675

Recuperating the biopharmaceutical aspects of amphotericin B and paromomycin using a chitosan functionalized nanocarrier via oral route for enhanced anti-leishmanial activity: Shabi Parvez, Ganesh Yadagiri, Archana Karole, Om Prakash Singh, Anurag Verma, Shyam Sundar and Shyam Lal Mudavath*, (2020) Front. Cell. Infect. Microbiol., . DOI: 10.3389/fcimb.2020.570573

Formulation, characterization, and in vitro anti-leishmanial evaluation of amphotericin b loaded solid lipid nanoparticles coated with vitamin B12-stearic acid conjugate: Aakriti Singh‡, Ganesh Yadagiri‡, Shabi Parvez, Om Prakash Singh, Anurag Verma, Shyam Sundar, Shyam Lal Mudavath*, (2020) Materials Science & Engineering C, 117: 111279. DOI: 10.1016/j.msec.2020.111279

Evaluation of Safety and Antileishmanial efficacy of Amine Functionalized Carbon-based Composite Nanoparticle appended with Amphotericin B: An In vitro and Preclinical Study: Mallikarjuna Rao Gedda,Prasoon Madhukar,Alok Kumar Vishwakarm,Vimal Verma,Anurag Kumar Kushwaha,Ganesh Yadagiri,Shyam Lal Mudavath,Om Prakash Singh,Onkar Nath Srivastava,Shyam Sundar, (2020) Front. Chem., . DOI: https://doi.org/10.3389/fchem.2020.00510

Improvising anti-leishmanial activity of Amphotericin B and Paromomycin using co-delivery in D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) tailored Nano-lipid carrier system: Shabi Parvez, Ganesh Yadagiri, Aakriti Singh, Archana Karole, Om Prakash Singh, Shyam Sundar,Shyam Lal Mudavath*, (2020) Chemistry and Physics of Lipids, 231: 104946. DOI: 10.1016/j.chemphyslip.2020.104946

Sensible graphene oxide differentiates macrophages and Leishmania: A Bio-nano interplay in attenuating intracellular parasite: Aakriti Singh‡, Sandeep Sharma‡, Ganesh Yadagiri, Shabi Parvez, Nikhil Koratkar, Om Prakash Singh, Shyam Sundar, Vijayakumar Shanmugam* and Shyam Lal Mudavath*, (2020) RSC Advances, 10: 27502–27511. DOI: DOI: 10.1039/d0ra04266h

Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: An effective oral combination against experimental murine visceral leishmaniasis: Shabi Parvez‡, Ganesh Yadagiri‡, Mallikarjuna Rao Gedda, Aakriti Singh, Om Prakash Singh, Anurag Verma, Shyam Sundar, Shyam Lal Mudavath*, (2020) Scientific Reports, 10: 12243. DOI: https://doi.org/10.1038/s41598-020-69276-5

Enkephalins as a therapeutic intervention for visceral leishmaniasis: Ganesh Yadagiri,Shyam Lal Mudavath*, (2020) Medical Hypotheses, 144: 109956. DOI: doi.org/10.​1016/​j.​mehy.​2020.​109956

Envisioning the innovations in nanomedicine to combat visceral leishmaniasis: for future theranostic application: Om Prakash Singh, Mallikarjuna Rao Gedda, Shyam Lal Mudavath, Onkar Nath Srivastava, Shyam Sundar, (2019) Nanomedicine, 14: 1911-1927. DOI: 10.2217/nnm-2018-0448

Mannose-conjugated curcumin-chitosan nanoparticles: Efficacy and toxicity assessments against Leishmania donovani: Chaubey P, Mishra B, Patel RR, Chaurasia S, Sundar S, Suvarna V, Monteiro M, (2018) Int J Biol Macromol, 111: 109-120. DOI: 10.1016/j.ijbiomac.2017.12.143

Galactosylated Chitosan for Enhanced and Efficient Antimicrobial and Antileishmanial Activities: A Novel Approach: Vishwakarma N.K.; Patel V.K.; Gundampati R.K.; Mudavath S.L.; Gupta T.; Ramesh K.; Jana K.K.; Dutta P.K.; Maiti P.; Mishra N.; Jagannadham M.V.; Sundar S.; Ray B., (2015) Asian Chitin J, 11: 11-18. DOI: NA

Characterization and evaluation of amine modified graphene Amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies: Talat M, Rai M, Srivastava ON, Sundar S, (2014) Drug Design, Development and Therapy, 8: 1235-47. DOI: 10.2147/DDDT.S63994

In vivo assessment of antileishmanial property of 4-(4, 4, 8-Trimethyl 7-oxo-3-oxabicyclo [3.3.1] non-2-yl)-benzoic acid methyl ester, an oxabicyclo [3.3.1] nonanones, in hamster model: Prakash Saudagar, Pipas Saha, Anil K. Saikia,Vikash Kumar Dubey,Shyam Sundar, (2014) Letters in Drug Design & Discovery, 11: 937-939. DOI: 10.2174/1570180811666140423203826

Comparative Evaluation of Blood and Serum Samples in Rapid Immunochromatographic Tests for Visceral Leishmaniasis: Kumar D, Khanal B, Tiwary P, Tiwary NK, Singh R, Koirala K, Boelaert M, Rijal S, Sundar S., (2013) J Clin Microbiol., 51(12): 3955-9.. DOI: 10.1128/JCM.01232-13